| Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 99.31M | 148.42M | 89.32M | 542.41M | 1.28B |
| Gross Profit | 5.12M | 8.86M | -10.95M | -111.81M | -72.46M |
| EBITDA | -48.11M | 13.26M | -78.38M | -313.55M | -324.61M |
| Net Income | -64.27M | 600.69M | -502.19M | -594.36M | -360.46M |
Balance Sheet | |||||
| Total Assets | 179.49M | 182.41M | 283.29M | 833.78M | 1.36B |
| Cash, Cash Equivalents and Short-Term Investments | 10.06M | 23.86M | 2.39M | 10.20M | 98.15M |
| Total Debt | 97.58M | 85.58M | 156.31M | 750.98M | 621.38M |
| Total Liabilities | 244.19M | 269.94M | 1.08B | 1.11B | 1.03B |
| Stockholders Equity | -64.04M | -72.58M | -788.65M | -272.27M | 330.82M |
Cash Flow | |||||
| Free Cash Flow | -98.49M | -69.47M | -1.14M | -169.45M | -265.79M |
| Operating Cash Flow | -96.56M | -69.47M | -157.00K | -138.98M | -234.83M |
| Investing Cash Flow | -2.05M | 3.65M | 10.97M | -29.25M | 6.02M |
| Financing Cash Flow | 78.63M | 96.07M | -17.11M | 82.93M | 219.06M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
54 Neutral | HK$260.61M | -22.59 | -11.38% | 8.70% | -16.95% | -461.16% | |
54 Neutral | HK$2.57B | 38.27 | 16.03% | 0.50% | 11.29% | 40.42% | |
48 Neutral | HK$11.97B | 24.30 | 2.01% | ― | 6.10% | -70.77% | |
45 Neutral | HK$3.22B | 3.98 | -177.99% | ― | ― | ― | |
43 Neutral | HK$636.38M | -0.92 | -17.57% | 4.61% | 0.48% | -86.42% | |
39 Underperform | HK$37.23M | -10.94 | 80.51% | ― | -0.76% | 93.44% |